Profile data is unavailable for this security.
About the company
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
- Revenue in USD (TTM)59.79m
- Net income in USD-18.54m
- Incorporated2009
- Employees149.00
- LocationCosmos Health Inc5 Agiou Georgiou, PileaTHESSALONIKI 554 38GreeceGRC
- Phone+1 3 125363102
- Websitehttps://www.cosmosholdingsinc.com/
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 31 Dec 2025 | 334.58k | 1.11% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 267.80k | 0.89% |
| Citadel Securities LLCas of 30 Sep 2025 | 225.31k | 0.75% |
| Geode Capital Management LLCas of 31 Dec 2025 | 198.68k | 0.66% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 140.01k | 0.46% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 95.74k | 0.32% |
| XTX Markets LLCas of 30 Sep 2025 | 65.49k | 0.22% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 45.24k | 0.15% |
| HRT Financial LPas of 31 Dec 2025 | 25.66k | 0.09% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025 | 20.55k | 0.07% |
